Monte Rosa, Novartis Use AI-Powered Engine To Advance Immune Disease Treatments
Monte Rosa’s stock jumps as it partners with Novartis to develop degraders for immune diseases, with up to $5.7 billion in payments. read more
BitMine Reports $10.8 Billion Ethereum, Bitcoin, ‘Moonshot’ Crypto Holdings
BitMine Immersion Technologies Inc (AMEX:BMNR) has amassed over 2.15 million ETH tokens worth approximately $10 billion, cementing its position as the world’ read more
MongoDB Gains Momentum As AI Use And Cloud Platform Growth Accelerate: Analyst
Wedbush analyst maintains Outperform rating for MongoDB, with raised price forecast and strong potential for growth in AI market. Latest Ratings for MDB Date Firm Action From To Mar 2022 Needham Maintains Buy Mar 2022 Mizuho Maintains Neutral Mar 2022 Barclays Maintains Overweight View More Analyst Ratings for MDB View the Latest Analyst Ratings read…
ATyr Pharma Stock Sinks, Plans FDA Review After Mixed Phase 3 Results
ATyr Pharma’s stock dips after Phase 3 trial of efzofitimod misses steroid reduction goal, but shows improvements in lung function and steroid withdrawal rates. read more
What’s Going On With Tempus AI Stock Monday?
Tempus AI stock is trading marginally lower on Monday. Recent bullish sentiment follows last Thursday’s announcement that Tempus AI received 510(k) clearance from the FDA. read more
What’s Going On With Nio Stock Monday?
Nio shares are trading higher Monday morning. The stock is rebounding from last week’s volatility caused by a capital raise. read more
Oracle Soars To Record Highs With Massive Cloud Contracts Tied To OpenAI
Oracle (NYSE: ORCL) stock continues to rise after historic surge fueled by OpenAI’s cloud spending. Year-to-date gain of 82% and nearing trillion-dollar club. read more